基本信息
浏览量:442
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
The division of Gastrointestinal Medical Oncology focuses on the development of new drugs and establishment of standard chemotherapy regimens including multimodality treatment with surgery and/or radiotherapy for advanced esophageal/gastric/colorectal cancers, gastrointestinal stromal tumor, and other gastrointestinal (GI) malignancies. The team does not only participate in many industry-sponsored trials but also conduct investigator-initiated trials, which are associated with translational research, in collaboration with many clinicians and basic researchers in Japan, Asia, and worldwide. Recently, the team has investigated biomarkers using pretreatment tumor and blood samples, including circulating tumor cell and cell-free DNA. Because easy access to tumor samples by endoscopy is a strong point in GI malignancy, the team is now preceding to translational research using repeated biopsy samples after administering investigational drugs.
研究兴趣
论文共 730 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yasuhide Yamada,Kengo Nagashima,Mizutomo Azuma,Mitsuko Masutani,Hitoshi Ichikawa,Satoru Iwasa,Naoki Takahashi,Hidekazu Hirano, Keisuke Kanato,Nozomu Machida,Takahiro Kinoshita, Hiroaki Hata,
BJC Reportsno. 1 (2024): 1-8
Journal of Clinical Oncologyno. 16_suppl (2024): 1511-1511
Journal of Geriatric Oncologyno. 5 (2024): 101778-101778
crossref(2024)
Hirotoshi Iihara,Masakazu Abe,Makoto Wada, Keiko Iino,Tatsuo Akechi,Chiyo K. Imamura,Ayako Okuyama, Keiko Ozawa,Yong-Il Kim,Hidenori Sasaki,Eriko Satomi, Masayuki Takeda,
International Journal of Clinical Oncologypp.1-16, (2024)
Masamitsu Kobayashi,Jun Kako, Arisa Iba,Ayako Okuyama, Keiko Ozawa,Masakazu Abe,Makoto Wada,Tatsuo Akechi,Hirotoshi Iihara,Chiyo K. Imamura,Yong-Il Kim,Hidenori Sasaki,
International Journal of Clinical Oncologypp.1-10, (2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn